Author:
Borrelli Umberto,Detroux Marc,Nottin Remi,Nikis Stephane,Nakers Pierre
Reference23 articles.
1. Butler J, Rocker GM, Westaby S. Inflammatory response to cardiopulmonary bypass. The Annals of Thoracic Surgery. 1993;55:552-559
2. Bracey AW, Radovancevic R. The hematologic effects of cardiopulmonary bypass and the use of hemotherapy in coronary artery bypass grafting. Arch Pathol Lab Med 93;118:411-416
3. Williamson LM, Lowe S, Love EM, Cohen H, Soldan K, McClelland DBL, Skacel P, Barbara JAJ. Serious hazards of transfusion (SHOT) initiative: Analysis of the first two annual reports. British Medical Journal. 1999;319:16-19
4. Moulton MJ, Creswell LL, Mackey ME, Cox JL, Rosembloom M. Reexploration for bleeding is a risk factor for adverse outcomes after cardiac operations. The Journal of Thoracic and Cardiovascular Surgery. 1996;111:1037-1046
5. Fromes Y, Gaillard D, Ponzio O, Chauffert M, Gerhardt MF, Deleuze P, Bical OM. Reduction of the inflammatory response following coronary bypass grafting with total minimal extracorporeal circulation. European Journal of Cardio-Thoracic Surgery. 2002;22:527-533